Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Evaluate historical worst drawdowns for index funds and translate insights into practical risk controls and withdrawal planning.
14,434 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
A surge in XRP trading on key exchanges has investors buzzing. This sign that better could point to shifting sentimen...
Grocery Outlet GO's Q4 2025 earnings transcript sheds light on margin discipline, expansion plans, and the path to 20...
A synthetic covered‑call ETF on MicroStrategy stock continues to pay outs through monthly distributions, yet the stra...
SpaceX aims for a record public debut valued at $1.75 trillion. History warns mega-IPOs can swing wildly in year one,...
In 2026, some AI-related players outshined Nvidia, delivering eye-popping gains and signaling a broader AI infrastruc...
A niche tanker freight ETF has surged roughly 700% this year, outperforming Micron. Here’s what’s driving the move, t...
Investors are eyeing Lilly for its resilient growth, strong pipeline, and shareholder-friendly strategy. This piece b...
Is Rivian a millionaire-maker stock or a high-risk punt? This guide dives into the catalysts, margins, and scenarios ...
Bitcoin is sliding off its all-time highs in what many call this bitcoin's shallowest bear. Learn what that means, wh...
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
Platinum demand and supply dynamics put the Aberdeen Physical Platinum Shares ETF in focus for longer-term investors....